Type 2 diabetes mellitus and multiple chronic diseases
https://doi.org/10.14341/DM9605
Abstract
Background: Recently, there has been an increase in the number of patients with multiple chronic diseases (MCD), particularly due to obesity and ageing. The role of type 2 diabetes mellitus (T2DM) in the development of MCD, however, is still unclear.
Aims: This study aimed to determine the incidence of T2DM in the structure of polymorbidity considering sex and age-related characteristics.
Materials and methods: Patients with MCD (n = 2,254; 769 men/1,485 women; aged, 18–99 years) were examined. The incidence of type 2 diabetes among patients with MCD considering age and sex was determined.
Results: Type 2 DM was detected in 407 patients with MCD (18.1%; male:female, 1:2.53). The polymorbidity index in male patients with type 2 diabetes was 1.5–2.0 times higher than that in male patients without diabetes. The rate of polymorbidity index increase was similar in both groups; however, its high initial value in patients with diabetes at a young age determined the burden of the comorbidity at a later age. In type 2 diabetes, hypertension was the predominant comorbidity at 18–59 years of age (p<0.05), whereas other cardiovascular diseases and liver and kidney diseases were predominant at 45–74 years of age (p<0.001) and hemiplegia at 45–89 years of age (p<0.05). Between 60 and 74 years, oncological diseases were found to be more common in patients without diabetes (p<0.001). Obesity, regardless of the presence of diabetes, was associated with a greater disease burden (p<0.05). Sex-related difference considering MCD in patients with type 2 DM was only observed for the higher incidence of myocardial infarction (p<0.001) and peptic ulcer disease in males (p<0.01). Females were more likely to have obesity, liver steatosis at a young age, or osteoarthritis than males in the general group (p<0.05); no differences were noted with respect to other diseases.
Conclusions: In this study, type 2 diabetes was present in 18.1% of patients with MCD; moreover, a high initial polymorbidity index in patients with T2DM at young age was associated with a higher incidence of chronic diseases later in life than that in patients without diabetes. Based on these results, type 2 diabetes, along with ageing and obesity, can be considered as a risk factor in the development of MCD.
About the Authors
Nailya S. AsfandiyarovaRyazan State Medical University
Russian Federation
MD, PhD, senior research associate
Olga V. Dashkevich
Ryazan State Medical University
Russian Federation
MD, PhD
Natalya V. Doroshina
Ryazan State Medical University
Russian Federation
Senior Lecturer
Ekaterina I. Suchkova
Ryazan State Medical University
Russian Federation
MD, PhD student
References
1. Сахарный диабет: диагностика, лечение профилактика / Под ред. Дедова И.И., Шестаковой М.В. – М.: Медицинское информационное агентство; 2011. [Dedov II, Shestakova MV, editors. Sakharnyi diabet: diagnostika, lechenie, profilaktika. Moscow: Meditsinskoe informatsionnoe agentstvo; 2011. (In Russ.)]
2. Вёрткин А.Л., Скотников А.С., Магомедова А.Ю., и др. Коморбидный больной сахарным диабетом на амбулаторном приеме у терапевта // Лечащий Врач. – 2014. – №3. – C. 18-24. [Vyortkin AL, Skotnikov AS, Magomedova AY, et al. Komorbidnyy bol'noy sakharnym diabetom na ambulatornom prieme u terapevta. Practitioner. 2014;(3):18-24. (In Russ.)]
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373-383. doi: 10.1016/0021-9681(87)90171-8
4. Dedov II, Shestakova MV, Benedetti MM, et al. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabetes Res Clin Pract. 2016;115:90-95. doi: 10.1016/j.diabres.2016.02.010
5. Лазебник Л.Б., Верткин А.Л., Конев Ю.В., и др. Старение. Профессиональный врачебный подход. – М.: Эксмо; 2014. [Lazebnik LB, Vyortkin AL, Konev YV, et al. Starenie. Professional’nyy vrachebnyy podkhod. Moscow: Eksmo; 2014. (In Russ.)]
6. Yates T, Khunti K. Epidemiology: The diabetes mellitus tsunami: worse than the 'Spanish flu' pandemic? Nat Rev Endocrinol. 2016;12(7):377-378. doi: 10.1038/nrendo.2016.74
7. Вёрткин А.Л., Петрик Е.А., Аристархова О.Ю. Полиморбидность – причина диагностических ошибок и расхождения клинического и морфологического диагноза // Врач скорой помощи. – 2011. – №4. – С. 63-66. [Vyortkin AL, Petrik EA, Aristarkhova OY. Polimorbidnost' – prichina diagnosticheskikh oshibok i raskhozhdeniya klinicheskogo i morfologicheskogo diagnoza. Vrach skoroy pomoshchi. 2011;(4):63-66. (In Russ.)]
8. Вёрткин А.Л.., Зайратьянц О.В., Вовк Е.И. Окончательный диагноз. – М.: ГЭОТАР-Медиа; 2008. [Vyortkin AL, Zairat’yants OV, Vovk EI. Okonchatel’nyy diagnoz. Moscow: GEOTAR-Media; 2008. (In Russ.)]
9. Сунцов Ю.И., Дедов И.И., Кудрякова С.В. Государственный регистр сахарного диабета: эпидемиологическая характеристика инсулиннезависимого сахарного диабета // Сахарный диабет. – 1998. – Т. 1. – №1. – C. 41-43. [Suntsov YI, Dedov II, Kudryakova SV. Gosudarstvennyy registr sakharnogo diabeta: epidemiologicheskaya kharakteristika insulinnezavisimogo sakharnogo diabeta. Diabetes mellitus. 1998;1(1):41-43. (In Russ.)] doi: 10.14341/2072-0351-6215
10. Nichols GA, Gullion CM, Koro CE, et al. The Incidence of Congestive Heart Failure in Type 2 Diabetes: An update. Diabetes Care. 2004;27(8):1879-1884. doi: 10.2337/diacare.27.8.1879
11. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 1974;34(1):29-34. doi: 10.1016/0002-9149(74)90089-7
12. Klimek P, Kautzky-Willer A, Chmiel A, et al. Quantification of diabetes comorbidity risks across life using nation-wide big claims data. PLoS Comput Biol. 2015;11(4):e1004125. doi: 10.1371/journal.pcbi.1004125
13. Кляритская И.Л., Максимова Е.В. Коморбидность сахарного диабета и заболеваний печени // Крымский терапевтический журнал. – 2012. – № 2. – С. 109-115. [Klyaritskaya IL, Maksimova EV. The combination of diabetes and liver disease. Krymskiy terapevticheskiy zhurnal. 2012;(2):109-115. (In Russ.)]
14. Климентьева Г.И., Курникова И.А., Кузнецова И.А., Афонова Т.М. Сахарный диабет 2 типа и проблема коморбидной патологии // Кубанский научный медицинский вестник. – 2012. – №1. – С. 81-84. [Klymentyeva GI, Kurnikova IA, Kuznetsova IA, Afonova TM. Type 2 diabetes and and the problem of comorbid pathology. Kubanskii nauchnyi meditsinskii vestnik. 2012;(1):81-84. (In Russ.)]
15. Kim HS, Shin AM, Kim MK, Kim YN. Comorbidity study on type 2 diabetes mellitus using data mining. Korean J Intern Med. 2012;27(2):197-202. doi: 10.3904/kjim.2012.27.2.197
16. Pati S, Schellevis FG. Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India). PLoS One. 2017;12(8):e0181661. doi: 10.1371/journal.pone.0181661
17. Mo F, Pogany LM, Li FC, Morrison H. Prevalence of diabetes and cardiovascular comorbidity in the Canadian Community Health Survey 2002-2003. ScientificWorldJournal. 2006;6:96-105. doi: 10.1100/tsw.2006.13
18. Stapleton A. Urinary tract infections in patients with diabetes. Am J Med. 2002;113(1):80-84. doi: 10.1016/s0002-9343(02)01062-8
19. Наумова Л.А., Осипова О.Н. Коморбидность: механизмы патогенеза, клиническое значение // Современные проблемы науки и образования. – 2016. – №5. [Naumova LA. Osipova NM. Comorbidity: mechanisms of pathogenesis, clinical significance. Modern problems of science and education. 2016;(5). (In Russ.)]
20. Пузырев В.П. Генетические основы коморбидности у человека // Генетика. – 2015. – Т. 51. – №4. – С. 491-502. [Puzyrev VP. Genetic Bases of Human Comorbidity. Russian journal of genetics. 2015;51(4):491-502. (In Russ.)] doi: 10.7868/S0016675815040098
21. Асфандиярова Н.С. Смертность при сахарном диабете 2 типа (обзор литературы) // Сахарный диабет. – 2015. – Т. 18. – №4. – С. 12-21. [Asfandiyarova NS. A review of mortality in type 2 diabetes mellitus. Diabetes mellitus. 2015;18(4):12-21. (In Russ.)] doi: 10.14341/DM6846
22. Асфандиярова Н.С., Низов А.А., Здольник Т.Д., и др. Динамика смертности при сахарном диабете на примере Сасовского района Рязанской области за период с 2003 по 2013 гг // Проблемы эндокринологии. – 2015. – Т. 61. – №6. – С. 17-22. [Asfandiyarova NS, Nizov AA, Zdol'nik TD, et al. Changes in diabetes mortality in Sasovo district of Ryazan region during 2003-2013 years. Problems of endocrinology. 2015;61(6):17-22. (In Russ.)] doi: 10.14341/probl201561617-22
23. Шестакова М.В. Можно ли избежать полипрагмазии при инсулиннезависимом сахарном диабете? // Сахарный диабет. – 1999. – Т. 2. – №1. – С. 28-29. [Shestakova MV. Mozhno li izbezhat' polipragmazii pri insulinzavisimom sakharnom diabete? Diabetes mellitus. 1999;2(1):28-29. (In Russ.)] doi: 10.14341/2072-0351-5730
24. Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом / Под ред. Дедова И.И., Шестаковой М.В., Майорова А.Ю. 8-й выпуск // Сахарный диабет. – 2017. – Т. 20. – №1S. – С. 1-112. [Dedov II, Shestakova MV, Mayorov AY, et al. Dedov II, Shestakova MV, Mayorov AY, editors. Standards of specialized diabetes care. 8th ed. Diabetes mellitus. 2017;20(1S):1-112. (In Russ.)] doi: 10.14341/DM20171S8
Supplementary files
|
1. Fig. 1. Structure of chronic diseases depending on the presence of diabetes mellitus (* p <0.05; ** p <0.01; *** p <0.001). | |
Subject | ||
Type | Исследовательские инструменты | |
View
(122KB)
|
Indexing metadata ▾ |
Review
For citations:
Asfandiyarova N.S., Dashkevich O.V., Doroshina N.V., Suchkova E.I. Type 2 diabetes mellitus and multiple chronic diseases. Diabetes mellitus. 2018;21(6):455-461. (In Russ.) https://doi.org/10.14341/DM9605

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).